Capecitabine Tablets USP 150 mg & 500 mg

SECTION 2: Hazards identification

Health hazards

Contains a cytotoxic agent. exposure by all routes of exposure must be avoided. In the workplace, exposure to dusts from product via inhalation and skin contact may cause irritation. Eye contact from dusts can cause mechanical irritation. In therapeutic use, the most common adverse effects reported have included diarrhea, hand-and-foot syndrome, nausea, vomiting, abdominal pain, fatigue/weakness, and excess bilirubin in blood. Therapeutic use can cause bleeding, and bone marrow depression and severe, possibly life-threatening gastrointestinal, liver and cardiovascular effects. Can cause harm to fetus during pregnancy. May cause adverse effects on fertility, based on animal data. This material has shown potential mutagenic effects. These effects may be possible as a result of workplace exposure. Flammability This product requires substantial pre-heating before ignition occurs. When involved in a fire, this product may decompose and produce irritating vapors and toxic compounds (including carbon, iron, magnesium, titanium and nitrogen oxides and hydrogen fluoride). Reactivity Hazards This product is not reactive

Environmental hazards

The active ingredient is acutely toxic to algae and chronically toxic to fish. Release of this product to the environment may cause harm to aquatic or terrestrial organisms. Emergency Emergency responders must wear personal protective equipment suitable Recommendations for the situation to which they are responding